CTS Spotlight at 2018 AABB Annual Meeting
Sunday, October 14, 2018 at 1:30 PM: Scientific Oral Abstract Plenary Session (BBC57) Multicenter Clinical Evaluation of a Babesia Transcription-Mediated Amplification Assay on a Fully Automated System Phillip C. Williamson, Ph.D.
Monday, October 15, 2018 at 2:30PM: (BBC2-MN3-24) Recently Acquired Hepatitis C Infections in US Blood Donors: Genotype and Geographic Distribution of NAT Yield Blood Donations across the Continental US Valerie Winkelman and Phillip C. Williamson, Ph.D.
Tuesday, October 16, 2018 at 11:45AM a: (PHP2 - TU3-23) Characteristics of HIV Infections, Including Genotypes and Drug Resistance Mutations, in Blood Donors in the US Phillip C. Williamson, Ph.D.
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...